Eurofins stock: At EUR 78.65, Eurofins stock sits near its EUR 79.22 52-week high
Published on 10/16/2026 at 16:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPrice position and valuation
- Eurofins will host an investor event on October 23, 2026.
- Goldman Sachs raised its 12-month target from EUR 85.00 to EUR 89.00 on October 6, 2026.
- Eurofins stock costs EUR 78.65 at Lang & Schwarz on October 16, 2026 at 4:35 p.m. CEST, below the 52-week high of EUR 79.22.
- Eurofins had a market capitalization of EUR 13.7 billion as of October 16, 2026.
Eurofins stock was trading at EUR 78.65 at Lang & Schwarz on October 16, 2026 at 4:35 p.m. CEST, placing the quote EUR 0.57 below its 52-week high of EUR 79.22. The company will host an investor event on October 23, 2026, at its campus in Amersfoort, Netherlands, according to Eurofins. Eurofins stock was trading at EUR 78.65 at Lang & Schwarz on October 16, 2026 at 4:35 p.m. CEST.
Investor event sets the next date
The October 23 event gives investors a specific calendar point before the next reported operating update. Eurofins also lists a second investor event in Toronto for November 11, 2026, according to Eurofins. The company published its first-half 2026 results on July 23, 2026, including 130 basis points of adjusted EBITDA margin expansion and 29 percent adjusted earnings-per-share growth, as stated on the investor page.
Quote remains near yearly high
The current Lang & Schwarz price is EUR 0.57 below the EUR 79.22 52-week high and above the EUR 54.86 low reported for the same quote series. That creates a EUR 24.36 spread between the yearly low and high. The finance quote showed 171,546 shares traded against an average volume of 289,642 shares as of October 16, 2026. Eurofins' 2025 revenue was EUR 7.296 billion, while its long-term average growth objective is 6.5 percent per year, according to Eurofins.
Target stands above the quote
Goldman Sachs raised its 12-month price target for Eurofins from EUR 85.00 to EUR 89.00 in a report dated October 6, 2026, while reiterating its Buy rating. The target was linked to a higher valuation multiple and expected 2.8 percent organic revenue growth for the third quarter of 2026. The same report lowered its full-year 2026 organic growth forecast from 2.7 percent to 2.3 percent.
Comparison with peers
These figures are dated October 16, 2026, and use the latest quotes for each listed company.
Eurofins: P/E 27.49, market capitalization EUR 13.7 billion
Bureau Veritas (Euronext Paris, EUR): 0.00 percent, P/E 24.71, market capitalization EUR 12.4 billion
SGS (SIX, CHF): minus 0.30 percent, P/E 28.85, market capitalization CHF 19.4 billion
Price and dates
Eurofins had a market capitalization of EUR 13.7 billion and a trailing P/E ratio of 27.49 as of October 16, 2026. The next investor dates listed by the company are October 23, 2026, in Amersfoort and November 11, 2026, in Toronto. The stock was trading at EUR 78.65 at Lang & Schwarz on October 16, 2026 at 4:35 p.m. CEST, below the EUR 79.22 52-week high. The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.
Eurofins market details
- Company: Eurofins Scientific SE
- ISIN: FR0014000MR3
- Price Lang & Schwarz (as of October 16, 2026, 4:35 p.m. CEST): EUR 78.65
- Market capitalization: EUR 13.7 billion (as of October 16, 2026)
- 52-week range: EUR 54.86-79.22 (as of October 16, 2026)
- Sector / Industry: Health care / analytical testing services
- Index membership: CAC 40
Market context: Market report CAC 40.
